AI assistant
IONIS PHARMACEUTICALS INC — Director's Dealing 2013
Apr 23, 2013
30591_dirs_2013-04-23_3cfb2b74-c1e4-4fd2-b3cb-f29233b63a10.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2013-04-19
Reporting Person: PARSHALL B LYNNE (Director, COO, Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-19 | Common Stock | M | 30000 | $7.26 | Acquired | 32941 | Direct |
| 2013-04-19 | Common Stock | S | 30000 | $20.006 | Disposed | 2941 | Direct |
| 2013-04-22 | Common Stock | M | 30000 | $11.12 | Acquired | 32941 | Direct |
| 2013-04-22 | Common Stock | S | 30000 | $20.99 | Disposed | 2941 | Direct |
| 2013-04-23 | Common Stock | M | 10000 | $11.12 | Acquired | 12941 | Direct |
| 2013-04-23 | Common Stock | S | 10000 | $22.0967 | Disposed | 2941 | Direct |
| 2013-04-23 | Common Stock | M | 10000 | $6.81 | Acquired | 10000 | Indirect |
| 2013-04-23 | Common Stock | S | 10000 | $22.0967 | Disposed | 0 | Indirect |
| 2013-04-23 | Common Stock | M | 10000 | $6.81 | Acquired | 10000 | Indirect |
| 2013-04-23 | Common Stock | S | 10000 | $22.0967 | Disposed | 0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-04-19 | Employee Stock Option (right to buy) | $7.26 | M | 30000 | Disposed | 2013-09-20 | Common Stock (30000) | Direct |
| 2013-04-22 | Employee Stock Option (right to buy) | $11.12 | M | 30000 | Disposed | 2014-01-01 | Common Stock (30000) | Direct |
| 2013-04-23 | Employee Stock Option (right to buy) | $11.12 | M | 10000 | Disposed | 2014-01-01 | Common Stock (10000) | Direct |
| 2013-04-23 | Employee Stock Option (right to buy) | $6.81 | M | 10000 | Disposed | 2014-01-01 | Common Stock (10000) | Indirect |
| 2013-04-23 | Employee Stock Option (right to buy) | $6.81 | M | 10000 | Disposed | 2014-01-01 | Common Stock (10000) | Indirect |
Footnotes
F1: Acquired as a result of exercising a stock option that was scheduled to expire on 9/20/2013. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/16/2012.
F2: Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/2014. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/31/2013.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.005 to $22.16, inclusive. The reporting person undertakes to provide to Isis Pharmaceuticals, Inc., any security holder of Isis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.